These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 16373913
1. Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes. Narita T, Hosoba M, Kakei M, Ito S. Diabetes Care; 2006 Jan; 29(1):142-4. PubMed ID: 16373913 [No Abstract] [Full Text] [Related]
2. Low dose of losartan decreased urinary excretions of IgG, transferrin, and ceruloplasmin without reducing albuminuria in normoalbuminuric type 2 diabetic patients. Narita T, Hosoba M, Miura T, Sasaki H, Morii T, Fujita H, Kakei M, Ito S. Horm Metab Res; 2008 Apr; 40(4):292-5. PubMed ID: 18548390 [No Abstract] [Full Text] [Related]
3. Diurnal changes in urinary excretion of IgG, transferrin, and ceruloplasmin depend on diurnal changes in systemic blood pressure in normotensive, normoalbuminuric type 2 diabetic patients. Hosoba M, Fujita H, Miura T, Morii T, Shimotomai T, Koshimura J, Yamada Y, Ito S, Narita T. Horm Metab Res; 2009 Dec; 41(12):910-5. PubMed ID: 19670106 [Abstract] [Full Text] [Related]
4. Hypertension increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin in normoalbuminuric patients with type 2 diabetes mellitus. Ohara N, Hanyu O, Hirayama S, Nakagawa O, Aizawa Y, Ito S, Sone H. J Hypertens; 2014 Feb; 32(2):432-8. PubMed ID: 24256706 [Abstract] [Full Text] [Related]
5. Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Narita T, Sasaki H, Hosoba M, Miura T, Yoshioka N, Morii T, Shimotomai T, Koshimura J, Fujita H, Kakei M, Ito S. Diabetes Care; 2004 May; 27(5):1176-81. PubMed ID: 15111541 [Abstract] [Full Text] [Related]
6. Combination effect of hypertension and diabetes mellitus on urinary protein excretion. Kawada T. J Hypertens; 2014 Nov; 32(11):2277. PubMed ID: 25271915 [No Abstract] [Full Text] [Related]
7. Combination effect of hypertension and diabetes mellitus on urinary protein excretion. Ohara N, Hanyu O, Sone H. J Hypertens; 2014 Nov; 32(11):2278. PubMed ID: 25271916 [No Abstract] [Full Text] [Related]
8. Glycemic control reverses increases in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminuria. Narita T, Fujita H, Koshimura J, Meguro H, Kitazato H, Shimotomai T, Kagaya E, Suzuki K, Murata M, Usami A, Ito S. Horm Metab Res; 2001 Jun; 33(6):370-8. PubMed ID: 11456288 [Abstract] [Full Text] [Related]
9. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G. Diabetes Care; 1999 Jul; 22(7):1176-80. PubMed ID: 10388985 [Abstract] [Full Text] [Related]
10. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Żyłka A, Dumnicka P, Kuśnierz-Cabala B, Gala-Błądzińska A, Ceranowicz P, Kucharz J, Ząbek-Adamska A, Maziarz B, Drożdż R, Kuźniewski M. Mediators Inflamm; 2018 Jul; 2018():7659243. PubMed ID: 30158836 [Abstract] [Full Text] [Related]
11. Urinary excretion of ceruloplasmin in relation to some other serum proteins in patients with proteinuria. Trip JA, Arisz L, van der Hem GK, Mandema E. Clin Chim Acta; 1968 Jul; 20(3):479-86. PubMed ID: 5654656 [No Abstract] [Full Text] [Related]
12. Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study. Uehara Y, Makino H, Seiki K, Urade Y, L-PGDS Clinical Research Group of Kidney. Nephrol Dial Transplant; 2009 Feb; 24(2):475-82. PubMed ID: 18799608 [Abstract] [Full Text] [Related]
13. Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy. Yamazaki M, Ito S, Usami A, Tani N, Hanyu O, Nakagawa O, Nakamura H, Shibata A. Eur J Endocrinol; 1995 Jun; 132(6):681-7. PubMed ID: 7788006 [Abstract] [Full Text] [Related]
14. Mechanism of increased serum cytokeratin 19 fragment levels in patients with diabetic nephropathy as a model of chronic renal failure. Kashiwabara K, Kishi K, Nakamura H, Yagyu H, Kobayashi K, Watanabe O, Matsuoka T. Intern Med; 1998 Nov; 37(11):917-21. PubMed ID: 9868951 [Abstract] [Full Text] [Related]
15. [Determinations of microproteinuria in early diabetic nephropathy]. Kawanishi K, Ishida T, Kajikawa T, Tada S. Rinsho Byori; 1995 May; 43(5):454-9. PubMed ID: 7783362 [Abstract] [Full Text] [Related]
16. Intermittent diabetic microalbuminuria: association with blood pressure, glycemic control, and protein intake. Cooper ME, O'Brien RC, Murray RM, Seeman E, Jerums G. J Diabet Complications; 1989 May; 3(2):92-8. PubMed ID: 2526146 [Abstract] [Full Text] [Related]
17. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Varghese A, Deepa R, Rema M, Mohan V. Postgrad Med J; 2001 Jun; 77(908):399-402. PubMed ID: 11375456 [Abstract] [Full Text] [Related]
18. Urinary copper excretion in type 2 diabetic patients with nephropathy. Ito S, Fujita H, Narita T, Yaginuma T, Kawarada Y, Kawagoe M, Sugiyama T. Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224 [Abstract] [Full Text] [Related]
19. Prevalence and associations of microalbuminuria in proteinuria-negative patients with type 2 diabetes in two regional hospitals in Cameroon: a cross-sectional study. Efundem NT, Assob JCN, Feteh VF, Choukem SP. BMC Res Notes; 2017 Sep 12; 10(1):477. PubMed ID: 28899432 [Abstract] [Full Text] [Related]
20. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy]. Yashima I, Hirayama T, Shiiki H, Kanauchi M, Dohi K. Nihon Jinzo Gakkai Shi; 1999 Dec 12; 41(8):787-96. PubMed ID: 10655727 [Abstract] [Full Text] [Related] Page: [Next] [New Search]